ESMO Publishes New Position Paper on Supportive and Palliative Care

Food and Healthcare Press Releases Friday December 15, 2017 15:00
LUGANO, Switzerland--15 Dec--PRNewswire/InfoQuest

ESMO, the leading professional organisation for medical oncology, published a position paper on supportive and palliative care [ https://doi.org/10.1093/annonc/mdx757   ], calling attention to the evolving and growing gap between the needs of cancer patients and the actual provision of patient-centred care.

"New studies show that there may be a gap between what doctors think is important for patients, and what patients really need [ http://www.esmo.org/Conferences/Past-Conferences/ESMO-2017-Congress/Press-Media/Press-Releases/Patients-Feel-Psycho-social-Impact-of-Chemo-More-Acutely-Than-Physical-Side-Effects   ] . With this position paper, we wanted to call attention to the fact that, as well as anti-tumour treatment, cancer patients need physical, psychological, social, spiritual support, at every stage of the disease, from diagnosis," said main author Karin Jordan, ESMO Faculty Coordinator.

Matti Aapro, co-author, MASCC Past-president, said: "Recent studies [ http://esmo.org/Conferences/Past-Conferences/ESMO-2017-Congress/Press-Media/Press-Releases/Triggers-a-New-Tool-to-Assess-Cancer-Patients-Palliative-Needs   ] show that palliative and supportive care not only improves treatment: it contributes to better use of existing resources, avoids waste and may also reduce the cost of treatment."

Patient reported outcomes should be highly encouraged as shown to be associated with better quality of life, fewer hospitalisations and even increased survival, compared with usual care.

"We hope that this paper will contribute to develop a generalised culture and acceptance of supportive and palliative care, worldwide," said Aapro. "Basic patient needs such as pain relief are still not being widely met [ http://www.esmo.org/Policy/Global-Opioid-Policy-Initiative   ]. Education is vital to make sure that essential supportive care is accessible to all cancer patients, everywhere."

ESMO position paper content:
  • Key patient-centred care interventions and training
  • End-of-life care
  • Role of multidisciplinary teams
  • Integrating healthcare resources
  • Research and resources in supportive and palliative care
Full story:   http://bit.ly/2AiD5qG

ESMO is the leading professional organisation for medical oncology. With 17,000 members representing oncology professionals from 150 countries worldwide, ESMO is the society of reference for oncology education and information.

media@esmo.org
+41-91-973-19-07
Source: European Society for Medical Oncology (ESMO)

Latest Press Release

Walgreens Boots Alliance and Microsoft establish strategic partnership to transform health care delivery

- Companies aim to improve health outcomes and lower overall costs with enhanced digital and retail experiences and an R&D commitment to build health care solutions through seven-year agreement Walgreens Boots Alliance Inc. (WBA) and Microsoft Corp....

Ascensia Diabetes Care Announces Global Partnership With POCTech to Distribute and Co-develop Continuous Glucose Monitoring Systems

Ascensia Diabetes Care today announced it has entered into a global alliance with Zhejiang POCTech, Co., Ltd (POCTech), a developer and manufacturer of continuous glucose monitoring (CGM) systems. (Logo:...

MGI Announces Milestone of 1,000 Sequencers Installed and Opens Early Access Program for Groundbreaking Ultra-High-Throughput Sequencer, MGISEQ-T7

MGI, established in 2016 as a subsidiary of global genomics leader BGI Group, announced it has reached a new milestone of 1,000 MGI sequencers installed in 16 countries. MGI Chief Operating Officer Dr. Hui Jiang also announced the availability of MGI's...

Gift of Life Donor Program is U.S. Leader in Saving Lives

For the 11th consecutive year, Gift of Life Donor Program is the nation's leading organ procurement organization (OPO), coordinating the most life-saving organs for transplant among all 58 U.S. OPOs. Gift of Life broke two national records in 2018,...

Helsinn Group Grants Exclusive Licensing Rights to Menarini for Pracinostat

Licensing rights are worldwide excluding US, Canada, Japan and South AmericaHelsinn, a Swiss pharmaceutical group focused on building quality cancer care products, and Menarini, an Italian biopharmaceutical Group active in 136 countries worldwide, today...

Related Topics